PSMB9 and neoplasm: As the above description, DOK2, GBP4, PSMB9, and NLRC5 were tumor suppressors, in this research, their expressions were decreased in patients with poor prognosis and the levels of the methylation sites on their promoter regions were increased (Figure 5(g)), the latter might hinder the expression of the former.